Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, open-label study to compare the effects of two different doses of recombinant human growth hormone on fat reduction and fasting metabolic parameters in HIV-1-infected patients with lipodystrophy.
Bickel M, Zangos S, Jacobi V, Lutz T, Knecht G, Goebel F, Staszewski S, Klauke S. Bickel M, et al. Among authors: jacobi v. HIV Med. 2006 Sep;7(6):397-403. doi: 10.1111/j.1468-1293.2006.00399.x. HIV Med. 2006. PMID: 16903985 Free article. Clinical Trial.
The Protease Inhibitor Transfer Study (PROTRA 1): abacavir and efavirenz in combination as a substitute for a protease inhibitor in heavily pretreated HIV-1-infected patients with undetectable plasma viral load.
Bickel M, Rickerts V, Stephan C, Jacobi V, Rottmann C, Dauer B, Carlebach A, Thalhammer A, Miller V, Staszweski S. Bickel M, et al. Among authors: jacobi v. HIV Med. 2005 May;6(3):179-84. doi: 10.1111/j.1468-1293.2005.00286.x. HIV Med. 2005. PMID: 15876284 Free article. Clinical Trial.
Long-term effect on body composition and metabolic parameters after treatment with recombinant human growth hormone (r-hGH) in HIV-1 infected patients with lipodystrophy.
Bickel M, Zangos S, Lutz T, Eisen J, Knecht G, Goebel FD, Crespi CM, Jacobi V, Staszewski S, Klauke S. Bickel M, et al. Among authors: jacobi v. Scand J Infect Dis. 2008;40(1):36-9. doi: 10.1080/00365540701487955. Epub 2007 Jul 6. Scand J Infect Dis. 2008. PMID: 17852925 Clinical Trial.
[Comparison of the effect of 2 therapy concepts in the treatment of Pneumocystis carinii pneumonia. Cotrimoxazole for 21 days versus sequential therapy with cotrimoxazole followed by pentamidine inhalation].
Helm EB, Staszewski S, Arasteh K, Jacobi V, Mulert R, Wegner R, Ottmann O, Brodt HR, L'age M, Stille W. Helm EB, et al. Among authors: jacobi v. Med Klin (Munich). 1990 Apr;85 Suppl 2:264-7. Med Klin (Munich). 1990. PMID: 2374529 Clinical Trial. German.
128 results